Citations as recorded by:

1. Invasive Candida Infections in Liver Transplant Recipients

Transplantation Direct, 2017, 3(5) p. e156

DOI: 10.1097/TXD.0000000000000673

Citations as recorded by: Cross Ref

2. Microbial epidemiology and risk factors of infections in recipients after DCD liver transplantation

Int J Clin Pract, 2016, 70 p. 17

DOI: 10.1111/ijcp.12812

Citations as recorded by: Cross Ref

3. In vitroactivity of Caspofungin combined with Fluconazole on mixedCandida albicansandCandida glabratabiofilm

Med. Myco., 2016, 54(4) p. 384

DOI: 10.1093/mmy/myv108

Citations as recorded by: Cross Ref

4. Caspofungin versus fluconazole as prophylaxis of invasive fungal infection in high-risk liver transplantation recipients: A propensity score analysis

Liver Transpl, 2016, 22(4) p. 427

DOI: 10.1002/lt.24391

Citations as recorded by: Cross Ref

5. Epidemiology of invasive fungal infections after liver transplantation and the risk factors of late-onset invasive aspergillosis

Journal of Infection and Chemotherapy, 2016, 22(2) p. 84

DOI: 10.1016/j.jiac.2015.11.005

Citations as recorded by: Cross Ref Google

6. Effect of Prophylactic Antifungal Protocols on the Prognosis of Liver Transplantation: A Propensity Score Matching and Multistate Model Approach

BioMed Research International, 2016, 2016 p. 1

DOI: 10.1155/2016/6212503

Citations as recorded by: Cross Ref

7. Invasive candidiasis in liver transplant patients: Incidence and risk factors in a pediatric cohort

Pediatr Transplantation, 2016, 20(2) p. 235

DOI: 10.1111/petr.12663

Citations as recorded by: Cross Ref Google

8. Caspofungin versus fluconazole as prophylaxis of invasive fungal infection in high‐risk liver transplantation recipients: A propensity score analysis

Year: 2016

Citations as recorded by: Google

9. Risk factors and prevalence for candidemia in liver transplant recipients without antifungal prophylaxis, 10-year follow-up

Year: 2016

Citations as recorded by: Google

10. Characteristics of vertebral osteomyelitis after liver transplantation

Clinical Microbiology and Infection, 2015, 21(6) p. 573

DOI: 10.1016/j.cmi.2015.01.018

Citations as recorded by: Cross Ref

11. Antimicrobial chitosan nanodroplets: new insights for ultrasound-mediated adjuvant treatment of skin infection

Future Microbiology, 2015, 10(6) p. 929

DOI: 10.2217/fmb.15.27

Citations as recorded by: Cross Ref Google

12. Bronchoalveolar Lavage Lateral-Flow Device Test for Invasive Pulmonary Aspergillosis in Solid Organ Transplant Patients

Transplantation, 2014, 98(8) p. 898

DOI: 10.1097/TP.0000000000000153

Citations as recorded by: Cross Ref

13. Positions and numbers of FKS mutations in Candida albicans selectively influence in vitro and in vivo susceptibilities to echinocandin treatment.

Antimicrob. Agents Chemother., 2014, 58 p. 3

DOI: 1

Citations as recorded by: Google

14. Fungal Infections After Liver Transplantation: Incidence and Outcome

Transplantation Proceedings, 2014, 46(7) p. 2314

DOI: 10.1016/j.transproceed.2014.07.056

Citations as recorded by: Cross Ref Google

15. First experience with brentuximab vedotin in posttransplant lymphoproliferative disorder after liver transplantation: Complete remission followed by lethal sepsis

Liver Transpl, 2014, 20(9) p. 1145

DOI: 10.1002/lt.23918

Citations as recorded by: Cross Ref

16. Randomized Trial of Micafungin for the Prevention of Invasive Fungal Infection in High-Risk Liver Transplant Recipients

Clinical Infectious Diseases,

DOI: 10.1093/cid/ciu1128

Citations as recorded by: Cross Ref Google

17. Bronchoalveolar lavage lateral-flow device test for invasive pulmonary aspergillosis in solid organ transplant patients: a semiprospective multicenter study

Year: 2014

Citations as recorded by: Google